| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $463.1M | +28.4% |
| Cost of Revenue | $198.7M | +24.9% |
| Gross Profit | $264.3M | +31.1% |
| R&D Expense | $900K | -30.8% |
| SG&A Expense | $169.0M | +38.1% |
| Operating Income | $95.3M | +17.9% |
| Pre-tax Income | $83.1M | +28.0% |
| Income Tax | $15.0M | -11.4% |
| Net Income | $58.2M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $222.8M | +355.2% |
| Accounts Receivable | $25.7M | +167.3% |
| Inventory | $108.0M | +12.2% |
| Current Assets | $417.1M | +110.5% |
| Total Assets | $763.8M | +54.8% |
| Current Liabilities | $75.0M | +67.4% |
| Long-term Debt | $293.6M | +18.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $57.4M | -14.4% |
| Capital Expenditures | $13.5M | +192.6% |
| Investing Cash Flow | -$31.7M | -201.4% |
| Financing Cash Flow | $148.3M | +215.6% |
| Free Cash Flow | $43.8M | -29.8% |
| +46.1% |
| EPS (Basic) | $3.18 | +42.0% |
| EPS (Diluted) | $3.11 | +45.3% |
| Total Liabilities |
| $391.8M |
| +29.3% |
| Stockholders' Equity | $372.0M | +95.4% |